KATHERINE VANDERLAAN: Open Payments
NPI 1255605283 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 41 payments from 17 companies in 2025. Trend: 2023 $393 · 2024 $497 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $169 |
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Lundbeck LLC | 2 | $50 |
| Alkermes, Inc. | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Novo Nordisk Inc | 2 | $33 |
| Exact Sciences Corporation | 1 | $28 |
Products named: REXULTI, FANAPT, VRAYLAR, QULIPTA, VIVITROL, Auvelity, JOURNAVX, CAPLYTA.
Industry payments across MI — which companies pay providers there.
